Brief electrical pulses increase membrane permeability, creating a temporary delivery window through which siRNA can enter cells. The electrical treatment enables uptake but does not provide the gene-silencing specificity itself. After entry, the siRNA directs sequence-matched messenger RNA degradation through the RNA-induced silencing complex, allowing targeted suppression without permanent genome modification.
Sequence complementarity determines which messenger RNA is recognized by the RNA-induced silencing complex. This matching links the introduced siRNA to a particular transcript rather than broadly suppressing protein production. As a result, investigators can examine the consequences of reducing a selected host or pathogen-related gene and relate that change to immune or infection-associated phenotypes.
siRNA electroporation produces transient gene suppression because it acts through messenger RNA degradation rather than changing the cell's genomic DNA. This distinction allows researchers to study the short-term consequences of reducing a gene while avoiding permanent genome modification. The approach is therefore useful when reversible functional perturbation is preferable to stable genetic alteration.
A general workflow combines cells, a selected siRNA, and an electroporation step that briefly increases membrane permeability. Following delivery, the introduced siRNA engages the RNA-induced silencing complex and reduces the corresponding messenger RNA and protein production. Investigators can then examine how the targeted reduction affects the cellular process under study, including immune or infection-related responses.
The method is particularly valuable for difficult-to-transfect cells, where conventional delivery may not efficiently introduce siRNA. Researchers can suppress host genes to study immune signaling, inflammatory responses, or pathogen entry, or target pathogen-related genes to investigate replication. These applications connect a selected gene to a measurable infection or immune phenotype through transient functional analysis.
By reducing production of a selected protein, siRNA electroporation supports functional studies of pathways involved in immunity and infection. Changes in pathogen entry, replication, signaling, or inflammation can help reveal whether the targeted gene contributes to those processes. The resulting evidence can also support evaluation of potential therapeutic targets without requiring permanent genomic modification.